Zhengye Biotechnology Holding Ltd (ZYBT) stock
ZYBTNasdaqPharmaceutical Preparations
$1.52+0.09 (+6.29%)
Close on Nov 17, 2026Market cap $72.03MP/E –Yield –
Zhengye Biotechnology operating margin
Operating margin is operating income as a percentage of revenue.
For fiscal 2025 it was -60.6%, against 8.8% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -60.6% | −69.4 |
| FY2024 | Dec 31, 2024 | 8.8% | −12.4 |
| FY2023 | Dec 31, 2023 | 21.3% | −4.0 |
| FY2022 | Dec 31, 2022 | 25.3% | – |
See a number that looks wrong?